Company Filing History:
Years Active: 2007
Title: Gabriele Heine: Innovator in Dementia Detection
Introduction
Gabriele Heine is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the detection of progressive chronic dementia diseases. His innovative work has the potential to improve the lives of many patients suffering from such conditions.
Latest Patents
Gabriele Heine holds a patent for a "Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents." This invention relates to defined peptides and their quantitative determination in the body fluids of patients suffering from progressive chronic dementia. The inventive peptides are derived from a protein precursor and are processed in a specific manner, with possible post-translational modifications. An increase in the concentrations of these peptides indicates the presence of progressive chronic dementia. This method can be used to control the course of the disease and develop therapeutic agents, particularly for conditions like Alzheimer's disease.
Career Highlights
Heine is associated with Biovision AG, where he continues to work on innovative solutions in the medical field. His research focuses on the quantitative determination of peptides that can serve as biomarkers for dementia, enhancing diagnostic accuracy and patient care.
Collaborations
Heine has collaborated with notable colleagues such as Norbert Lamping and Hans-Dieter Zucht. Their combined expertise contributes to the advancement of research in dementia detection and treatment.
Conclusion
Gabriele Heine's work in the detection of progressive chronic dementia represents a significant advancement in medical diagnostics. His innovative methods and collaborations are paving the way for improved patient outcomes in the fight against dementia.